Clearance Summary
V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo Control received FDA 510(k) clearance under submission number K192931, sponsored by Helena Laboratories, Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2022-04-19.
- Submission: K192931
- Applicant / Sponsor: Helena Laboratories, Corp.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7415
- Decision date: 2022-04-19
Classification & Regulation
This clearance is catalogued under FDA product code GKA and 21 CFR 864.7415, within the Hematology review panel as a Class II device.